BioMarin Reports Fourth Quarter and Full Year 2024 Results; Sets Full Year 2025 Guidance
Portfolio Pulse from
BioMarin reported strong financial results for Q4 and FY 2024, with significant revenue growth. The company anticipates continued double-digit growth in 2025.
February 19, 2025 | 9:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BioMarin reported Q4 2024 revenues of $747 million, a 16% increase year-over-year, and FY 2024 revenues of $2.85 billion, an 18% increase. The company expects double-digit growth in 2025.
BioMarin's strong financial performance in 2024, with significant revenue growth, is likely to positively impact its stock price. The company's guidance for continued double-digit growth in 2025 further supports a positive outlook.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100